A Study on the Effect of Obstructive Sleep Apnea on Lipid Profile
Creators
- 1. Assistant Professor, Department of Physiology, Katihar Medical College, Katihar, Bihar, India
- 2. Consultant Medical Oncologist, Department of Oncology, City Hospital, Nottingham, England
- 3. Assistant Professor, Department of Anatomy, Government Medical College, Kannauj, Uttar Pradesh, India
- 4. Assistant Professor, Department of Physiology, Autonomous State Medical College, Firozabad, Uttar Pradesh, India
Description
Objectives: This present study was to evaluate the effect of obstructive sleep apnea on lipid profile in terms of AHI. Methods: A total of 60 participants of sleep apnea with age group of 25 to 65 years were enrolled in this study. All the subjects were divided into two groups. Each group had 30 subjects. Group A participants had AHI>10 and group B had AHI≤10. Polysomnography and relevant blood investigation were performed to all subjects. Results: Mean ± Standard deviation of Age, AHI, BMI, total cholesterol, triglycerides, HDL cholesterol, VLDL cholesterol and LDL cholesterol were 52.61 ± 12.23, 49.42 ± 36.43, 34.87± 7.22, 183.71 ± 52.12, 175.91 ± 98.76, 33.82 ± 12.24, 32.12 ± 12.38, 122.92 ± 47.98 respectively in group A participants. Similarly, mean ± Standard deviation of Age, AHI, BMI, total cholesterol, triglycerides, HDL cholesterol, VLDL cholesterol and LDL cholesterol were 47.34 ± 16.21, 4.85 ± 4.16, 26.98 ± 4.89, 164.52 ± 33.98, 128.83 ± 54.72, 39.12 ± 14.21, 26.93 ± 11.97, 99.23 ± 42.24 respectively in group B participants. Conclusions: Group A participants had increased BMI, total cholesterol, triglyceride, VLDL, LDL-Cholesterol, and decreased level of HDL -Cholesterol as compared to group B participants. Hence, AHI>10 participants were associated with changed lipid profile as compared to AHI≤ 10 participants.
Abstract (English)
Objectives: This present study was to evaluate the effect of obstructive sleep apnea on lipid profile in terms of AHI. Methods: A total of 60 participants of sleep apnea with age group of 25 to 65 years were enrolled in this study. All the subjects were divided into two groups. Each group had 30 subjects. Group A participants had AHI>10 and group B had AHI≤10. Polysomnography and relevant blood investigation were performed to all subjects. Results: Mean ± Standard deviation of Age, AHI, BMI, total cholesterol, triglycerides, HDL cholesterol, VLDL cholesterol and LDL cholesterol were 52.61 ± 12.23, 49.42 ± 36.43, 34.87± 7.22, 183.71 ± 52.12, 175.91 ± 98.76, 33.82 ± 12.24, 32.12 ± 12.38, 122.92 ± 47.98 respectively in group A participants. Similarly, mean ± Standard deviation of Age, AHI, BMI, total cholesterol, triglycerides, HDL cholesterol, VLDL cholesterol and LDL cholesterol were 47.34 ± 16.21, 4.85 ± 4.16, 26.98 ± 4.89, 164.52 ± 33.98, 128.83 ± 54.72, 39.12 ± 14.21, 26.93 ± 11.97, 99.23 ± 42.24 respectively in group B participants. Conclusions: Group A participants had increased BMI, total cholesterol, triglyceride, VLDL, LDL-Cholesterol, and decreased level of HDL -Cholesterol as compared to group B participants. Hence, AHI>10 participants were associated with changed lipid profile as compared to AHI≤ 10 participants.
Files
IJPCR,Vol14,Issue9,Article150.pdf
Files
(305.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:462c58dad525919b54e6774aa1e19a0a
|
305.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-09-23
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue9,Article150.pdf
- Development Status
- Active
References
- 1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 199 3;328:1230-5. 2. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976; 27:465-84. 3. Dempsey J, Veasey S, Morgan B, O'Donnel C. Pathophysiology of sleep apnea. Physiol Rev. 2010; 90: 47–112. 4. Malhotra A, Loscalzo J. Sleep and cardiovascular disease: an overview. Prog Cardiovas Dis. 2009; 51:279-284. 5. Barros D., García-Río F. Obstructive sleep apnea and dyslipidemia: From animal models to clinical evidence. Sleep 2019; 42: zsy236. 6. Khatana C., Saini N.K., Chakrabarti S., Saini V., Sharma A., Saini R.V., Saini A.K. Mechanistic Insights into the Oxidized Low-Density LipoproteinInduced Atherosclerosis. Oxid. Med. Cell. Longev. 2020; 2020: 1–14. 7. Smith S.S., Waight C., Doyle G., Rossa K.R., Sullivan K.A. Liking for high fat foods in patients with Obstructive Sleep Apnoea. Appetite 2014; 78: 185–192. 8. Jun J.C., Shin M.-K., Yao Q., BevansFonti S., Poole J., Drager L.F., Polotsky V.Y. Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice. Am. J. Physiol. Endocrinol. Metab. 2012; 303: e377–e 388. 9. Li J., Grigoryev D., Ye S.Q., Thorne L., Schwartz A.R., Smith P.L., O'Donnell C.P., Polotsky V.Y. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J. Appl. Physiol. 2005; 99:1643–1648. 10. Barceló A., Piérola J., De La Peña M., Esquinas C., Fuster A., Sánchez-De-LaTorre M., Carrera M., AlonsoFernández A., Ladaria A., Bosch M. et al. Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea. Eur. Respir. J. 2010; 37: 1418–1423. 11. Bikov A., Lazar Z., Horvath P., Tarnoki D.L., Tarnoki A.D., Fesus L., Horvath M., Meszaros M., Losonczy G. Kunos L. Association Between Serum Lipid Profile and Obstructive Respiratory Events During REM and Non-REM Sleep. Lung 2019; 197: 443– 450. 12. McNicholas WT, Bonsignore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-7813. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc; 2008; 5: 136-43. 14. Newman AB, Nieto FJ. Relation of sleep-disordered breathing to cardiovascular disease risk factors—the Sleep Heart Health Study. Am J Epidemiol. 2001; 154: 50–59. 15. Lam JC, Lam B, Lam CL et al. Obstructive sleep apnea and the metabolic syndrome in communitybased Chinese adults in Hong Kong. Respir Med. 2006; 100: 980-987. 16. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162(8):893-900. 17. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med. 2001;16 3(3 pt 1):608-613. 18. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998;157(1):144-148. 19. Ibrahim AS, Almohammed AA, Allangawi MH, et al. Predictors of obstructive sleep apnea in snorers .Ann Saudi Med 2008; 28(1):64. 20. Jianguo Li, Vladimir Savransky, Ashika Nanayakkara, Philip L. Smith, Christopher P. O'Donnell, Vsevolod Y. Polotsky. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. Journal of Applied Physiology Published 1 February 2007; 102(2): 557-563. 21. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000; 118: 580–586. 22. Kawano Y1, Tamura A, Kadota J. Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol. 2012; Feb;61(2):186-92. 23. Shimizu Y., Yoshimine H., Nagayoshi M., Kadota K., Takahashi K., Izumino K., Inoue K., Maeda T. Serum triglyceride levels in relation to highdensity lipoprotein cholesterol (TGHDL) ratios as an efficient tool to estimate the risk of sleep apnea syndrome in non-overweight Japanese men. Environ. Health Prev. Med. 2016; 21: 321–326. 24. Wu W.-T., Tsai S.-S., Shih T.-S., Lin M.-H., Chou T.-C., Ting H., Wu T.-N., Liou S.-H. The Association between Obstructive Sleep Apnea and Metabolic Markers and Lipid Profiles. PLoS ONE 2015; 10: e0130279. 25. Silva L.O.E., Guimarães T.D.M., Luz G.P., Coelho G., Badke L., Almeida I.R., Millani-Carneiro A., Tufik S., Bittencourt L., Togeiro S.M. Metabolic Profile in Patients with Mild Obstructive Sleep Apnea. Metab. Syndr. Relat. Disord. 2018;16: 6–12. 26. Gileles-Hillel A., Kheirandish-Gozal L., Gozal D. Biological plausibility linking sleep apnoea and metabolic dysfunction. Nat. Rev. Endocrinol. 2016; 12: 290–298. 27. Barceló A, Barbé F, Llompart E, et al. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 2004; 117:118-21 28. Salord N, Mayos M, Miralda R, Perez A. Respiratory sleep disturbances in patients undergoing gastric bypass surgery and their relation to metabolic syndrome. Obes Surg 2009; 19:74-9. 29. Monneret D, Borel JC, Pepin JL, et al. Pleiotropic role of IGF-I in obesity hypoventilation syndrome. Growth Horm IGF Res 2010; 20:127-33. 30. Peled N, Kassirer M, Shitrit D, et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med 2007; 101:169 6- 701.31. Atbib Y., Essad A., Zhar H., Tadlaoui Yasmina, Ait E Cadi, M., & Bousliman Y. Impact de l'immunothérapie dans la prise en charge du cancer du poumon. Etude rétrospective menée à l'Hôpital Militaire d'Instruction Mohammed VRabat. Journal of Medical Research and Health Sciences, 2022;5(9): 2221– 2243.